Investor Presentaiton
Share of B2C Business in Focus Cities (Non-Covid) at 60% in 9MFY23
METROPOLIS
The Pathology Specialist
B2C
Ratio
B2C Contribution in Focus Cities (Non-Covid Business) (Rs. in Crs.)
52%
56%
58%
60%
60%
+13.8%
344
269
258
233
295
FY19
FY20
FY21
FY22
9MFY23
✓ Excluding Covid-19 revenues, our B2C contribution
continues to increase
✓ Our aspirations is to achieve 65% B2C contribution in
focused cities in coming years remains intact, driven
by;
Aggressive network expansion to go closer to the
patient
Integrated Brand building campaigns to establish
Metropolis as a trusted brand in the mind of
consumer and the doctor
Building awareness amongst doctors for quality
and service differentiators of Metropolis vs the
unorganized sector.
➤ Obsessively monitoring customer experience and
generating a Net Promoters Score (NPS)
Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021; data excl. Covid & allied test
12View entire presentation